Long-acting β-agonists and inhaled corticosteroids: Is the whole greater than the sum of its parts?

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 2, 2010, Pages 357-358

  Kazani, Shamsah ^a   Israel, Elliot ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CCAAT ENHANCER BINDING PROTEIN ALPHA; CORTICOSTEROID; CYCLIC AMP; EOTAXIN; GLYCINE; GUANINE NUCLEOTIDE BINDING PROTEIN; SCLEROPROTEIN;

ACETYLATION; ASTHMA; CELL PROLIFERATION; EDITORIAL; EOSINOPHIL; GENETIC POLYMORPHISM; HUMAN; IN VITRO STUDY; MAST CELL; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ASTHMA; BRONCHODILATOR AGENTS; DRUG COMBINATIONS; HUMANS;

EID: 75849142219     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.12.021     Document Type: Editorial

References (15)

1. Johnson M. Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation. J Allergy Clin Immunol 117 (2006) 18-25
2. Chong L.K., Cooper E., Vardey C.J., and Peachell P.T. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms. Br J Pharmacol 123 (1998) 1009-1015
3. Goulet S., Bihl M.P., Gambazzi F., Tamm M., and Roth M. Opposite effect of corticosteroids and long-acting beta(2)-agonists on serum- and TGF-beta(1)-induced extracellular matrix deposition by primary human lung fibroblasts. J Cell Physiol 210 (2007) 167-176
4. Tomlinson P.R., Wilson J.W., and Stewart A.G. Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture. Br J Pharmacol 111 (1994) 641-647
5. Broadley K.J. Beta-adrenoceptor responses of the airways: for better or worse?. Eur J Pharmacol 533 (2006) 15-27
6. Roth M., Johnson P.R., Rüdiger J.J., King G.G., Ge Q., Burgess J.K., et al. Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet 360 (2002) 1293-1299
7. Usmani O.S., Ito K., Maneechotesuwan K., Ito M., Johnson M., Barnes P.J., et al. Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. Am J Respir Crit Care Med 172 (2005) 704-712
8. Kelly M.M., O'Connor T.M., Leigh R., Otis J., Gwozd C., Gauvreau G.M., et al. Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. J Allergy Clin Immunol 125 (2010) 349-356
9. Li X., Ward C., Thien F., Bish R., Bamford T., Bao X., et al. An antiinflammatory effect of salmeterol, a long-acting beta(2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma. Am J Respir Crit Care Med 160 (1999) 1493-1499
10. Nie M., Knox A.J., and Pang L. beta2-Adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation. J Immunol 175 (2005) 478-486
11. Oliver M.N., Fabry B., Marinkovic A., Mijailovich S.M., Butler J.P., and Fredberg J.J. Airway hyperresponsiveness, remodeling, and smooth muscle mass: right answer, wrong reason?. Am J Respir Cell Mol Biol 37 (2007) 264-272
12. Pauwels R.A., Löfdahl C.-G., Postma D.S., Tattersfield A.E., O'Byrne P., Barnes P.J., et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 337 (1997) 1405-1411
13. Wechsler M.E., Kunselman S.J., Chinchilli V.M., Bleecker E., Boushey H.A., Calhoun W.J., et al. Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. Lancet 374 (2009) 1754-1764
14. Nelson H.S., Weiss S.T., Bleecker E.R., Yancey S.W., and Dorinsky P.M. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129 (2006) 15-26
15. Statistical Briefing Package. Long-acting beta-agonists and adverse asthma events meta-analysis. US Food and Drug Administration (2008). http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4398b1-01-FDA.pdf Accessed January 16, 2009